SEC Form 4 · accession 0001562180-15-000077
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy Wolbeck
Officer — V.P. Regulatory Affairs & Qlty
Period of report
Feb 11, 2015
Accepted (ET)
Feb 13, 2015 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 11, 2015 | S | 2,901 | $22.05 | D | 0 | D | |
| Common Stock | Feb 12, 2015 | M | 5,099 | $1.00 | A | 5,099 | D | |
| Common StockF2 | Feb 12, 2015 | S | 5,099 | $22.1599 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.00 | Feb 12, 2015 | M | 5,099 | D | — | Feb 2, 2019 | Common Stock | 5,099 | 12,401 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2014.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.11 to $22.37, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3The shares subject to the option are immediately exercisable. 25% of the shares subject to the option vested on January 5, 2010 and 1/48th of the shares subject to the option vests monthly thereafter over there (3) years.